Search

Search any products, services and so on here.

About 21354 result(s)

Global Calcium Tablets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216716
  • Pages: 78
  • Figures: 76
  • Views: 27
  • From $4,250

The global Calcium Tablets market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Calcium tablets are elemental forms of calcium, an essential mineral for human health that may be taken to supplement calcium obtained from dietary sources or to address a calcium deficiency. Most supplements contain one o...


Global Glucagon Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216719
  • Pages: 80
  • Figures: 80
  • Views: 34
  • From $4,250

The global Glucagon market size was US$ 625 million in 2024 and is forecast to a readjusted size of US$ 941 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031. Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the blo...


Global Opioids Drug Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216727
  • Pages: 97
  • Figures: 92
  • Views: 26
  • From $4,250

The global Opioids Drug market size was US$ 9694 million in 2024 and is forecast to a readjusted size of US$ 8552 million by 2031 with a CAGR of -1.8% during the forecast period 2025-2031. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®...


Global Oxyclozanide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • May 05, 25
  • ID: 216788
  • Pages: 99
  • Figures: 94
  • Views: 33
  • From $4,250

The global Oxyclozanide market size was US$ 33.8 million in 2024 and is forecast to a readjusted size of US$ 64.8 million by 2031 with a CAGR of 9.9% during the forecast period 2025-2031. Oxyclozanide is a salicylanilide anthelmintic. It is used in the treatment and control of fascioliasis in ruminants mainly domestic animals such as cattle, sheep, and goats. It mainly acts by uncoupling of oxida...


Global Empagliflozin Drug Market Research Report 2025

  • May 05, 25
  • ID: 207374
  • Pages: 85
  • Figures: 83
  • Views: 31
  • From $2,900

The global market for Empagliflozin Drug was valued at US$ 19490 million in the year 2024 and is projected to reach a revised size of US$ 51550 million by 2031, growing at a CAGR of 15.7% during the forecast period. Empagliflozin is an oral antidiabetic drug that belongs to the class of SGLT2 (sodium-glucose co-transporter 2) inhibitors. It works by reducing glucose reabsorption in the kidneys, le...


Global Biktarvy Market Research Report 2025

  • May 05, 25
  • ID: 207379
  • Pages: 87
  • Figures: 81
  • Views: 38
  • From $2,900

The global market for Biktarvy was valued at US$ 15760 million in the year 2024 and is projected to reach a revised size of US$ 19070 million by 2031, growing at a CAGR of 2.7% during the forecast period. Biktarvy (Chinese trade name: Bituowei) is a fixed-dose combination antiretroviral drug used to treat human immunodeficiency virus type 1 (HIV-1) infection. It consists of three active ingredient...


Global Dupilumab Drug Market Research Report 2025

  • May 05, 25
  • ID: 207381
  • Pages: 76
  • Figures: 71
  • Views: 29
  • From $2,900

The global market for Dupilumab Drug was valued at US$ 18570 million in the year 2024 and is projected to reach a revised size of US$ 36530 million by 2031, growing at a CAGR of 10.3% during the forecast period. Dupilumab is a fully human monoclonal antibody used to treat a range of chronic inflammatory conditions driven by type 2 inflammation, such as moderate-to-severe atopic dermatitis, asthma,...


Global Elasomeran Market Research Report 2025

  • May 05, 25
  • ID: 216499
  • Pages: 74
  • Figures: 67
  • Views: 39
  • From $2,900

The global market for Elasomeran was valued at US$ 428 million in the year 2024 and is projected to reach a revised size of US$ 339 million by 2031, growing at a CAGR of -2.2% during the forecast period. Elasomeran is an mRNA vaccine developed collaboratively by the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna Inc., primarily designed to prevent COVID-19 infection. The...


Global Coronary Artery Bypass Grafts (CABG) Market Research Report 2025

  • Apr 23, 25
  • ID: 214367
  • Pages: 76
  • Figures: 79
  • Views: 184
  • From $2,900

The global market for Coronary Artery Bypass Grafts (CABG) was valued at US$ 142 million in the year 2024 and is projected to reach a revised size of US$ 202 million by 2031, growing at a CAGR of 5.2% during the forecast period. Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to rest...


Global Diagnostic Reagent Market Research Report 2025

  • Apr 23, 25
  • ID: 214374
  • Pages: 91
  • Figures: 95
  • Views: 52
  • From $2,900

The global market for Diagnostic Reagent was valued at US$ 69630 million in the year 2024 and is projected to reach a revised size of US$ 92500 million by 2031, growing at a CAGR of 4.2% during the forecast period. Diagnostic Reagent is any reagent that is used in vitro or in vivo for detection or screening of a particular disease or any health-related issue. Global Diagnostic Reagent key players...


Our team would be happy to assist you with your queries.

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232